MCMaria Elvira Ribeiro Cordeiro

Maria Elvira Ribeiro Cordeiro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria Elvira Ribeiro Cordeiro has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PI3K/AKT/mTOR Inhibitor Drug Candidates for the Treatment of Hormone Resistant Breast Cancer: A Systematic Review

    by Lucas Bernardim de Oliveira, Bárbara Mendes Paz Chao, Ana Carolina Dorigoni Bini, Maria Elvira Ribeiro Cordeiro, Emerson Carraro

    Breast cancer is the second most diagnosed type of cancer in women, with approximately 2.3 million cases reported in 2020. According to estimates by Brazil's National Cancer Institute, there will be approximately 74,000 new cases in the three-year period 2023-2025. It is divided into 4 molecular subtypes, Luminal A, Luminal B (hormone-positive), HER-2 and triple-negative. Regarding treatment, particularly for the luminal subtypes, hormone therapy is fundamental, since they grow from estrogen stimulation. However, processes can occur that lead to therapeutic resistance, such as mutations in the PI3K/AKT/mTOR pathway, which acts in the regulation of various cellular functions. The search for drugs that inhibit this pathway as an alternative treatment may play a key role in overcoming this resistance. This systematic review aimed to study new candidate drugs for inhibiting the PI3K/AKT/mTOR pathway as an alternative treatment in cases of resistance to hormone therapy. The study was conducted in accordance with the PRISMA guidelines, using the PubMed database with the following terms: "breast cancer", "PI3K/AKT/mTOR", "immunotherapy" without restriction of year and language. A total of 36 articles were found and 3 were included in this review. The drug candidates presented promising results in terms of inhibiting the PI3K/AKT/mTOR pathway, as well as some advantages such as a reduction in adverse effects, an increase in the average density of cytotoxic T cells and greater expression of interferon signaling genes, which through their immunoregulatory function lead to an increase in the body's ability to react to tumor cells. Despite this, there is still a need for more studies on the subject, especially in vivo studies that can assess the biosafety and efficacy profile, with the aim of compiling sufficient data to make the introduction of these new drugs in breast cancer therapy a reality.


  • Anti-Inflammatory Effects of Nanoparticles Containing Alpha-Humulene in a Model of Alzheimer's Disease

    by Sabrina Aparecida Wendler, Jéssica Roberta Nunes, Lais Fernanda Dranski, Maria Elvira Ribeiro Cordeiro, Rubiana Mara Mainardes, Christiane Schineider Machado, Ana Carolina Dorigoni Bini, João Alfredo Schiewe, Livia Hoyer Garcia Miranda, Ivo Ilvan Kerppers

    Alzheimer's disease (AD) is a neurodegenerative disorder that causes impairment in daily living activities. Although there is no consensus on the pathophysiology of this disease, neuroinflammation is known to be associated with this disease. Objective: To evaluate the anti-inflammatory effects of nanoparticles containing alpha-humulene (HUM) in an experimental model of AD. Methodology: Thirty-three animals were included in the sample, 3 of which were in the negative control group. The other 30 patients received the amyloid-beta peptide in the CA1 region of the hippocampus for neuroinflammation. The cells were allowed to rest for 30 days for the inflammatory process to occur. The HUM group was treated with α-humulene particles, the NHUM group was treated with α-humulene nanoparticles for 15 days, and the CP group was not treated. Results: There were significant differences in IFN concentrations between the CP and CN (p=0.0001), HUM and CN (p=0.0003), CP and NHUM (p=0.0006), and HUM and NHUM (p=0.0495) groups. There was no difference in TNF-α levels between the groups. IL-6 levels were significantly different between the CP and NHUM groups (p=0.0078) and between the CP and CN groups (p=0.0009). IL-12 levels were significantly different between the CP and CN (p=0.0001) and between the NHUM and CN (p=0.0160). Overall, the highest concentration was in the CP group. Concerning IL-10, there was a difference between the CP and NHUM (p=0.0003) and between the NHUM and CN (p=0.0005), with the NHUM having the highest concentration. Immunohistochemistry analysis of the anti-Tau and anti-GAPF antibodies revealed strong positivity in the CP group, positivity in the HUM group, and weak positivity in the NHUM group. Conclusion: Treatments for Alzheimer's disease and HUM and NHUM were effective.


  • Open Access

    Quantitative and qualitative analysis of neuroinflammation by beta amyloid 1-42 toxin after treatment with resveratrol-loaded nanoparticles

    by Mariane Maria Silveira Vieira de Lima, Maria Elvira Ribeiro Cordeiro, Flávio Klinpovous Kerppers, Ketllin Bragnholo, Luiza Ferreira Cunha, Maiara Fonseca, Tatiane Budniak Mazur, Christiane Schineider Machado, Rubiana Mara Mainardes, Afonso Shiguemi Inoue Salgado, et al.

    Background: This study evaluated the effects of zein nanoparticles with resveratrol on neuroinflammation caused by Alzheimer’s disease. Method: The sample consisted of 30 animals divided into control (C), positive control (CP), white nanoparticles (NB), resveratrol nanoparticles (NR) and resveratrol (R) groups. The animals received 10 mg/kg of resveratrol or nanoparticles according to the group, daily, for 15 days, oral administration. Afterward, they weresubmitted to immunohistochemical (IHC) analyses. Results: the IHC showed that there was no change in the morphological brain composition in the NR and C groups. Conversely, in the CP, NB, and R groups, changes in the deposition of Anti Tau were observed. The NR group showed a normal projection of taurine in the axon, which was not presented in the same way in the other groups. The CD68 marker showed no microglial activation in the R and C groups. Quantitative analyses of Anti Beta-Amyloid in the NR group showed a statistical difference comparedto the CP, NB, and R groups, whereas the Anti Tau analysis showed a significant difference between the CP and NR groups. The CD68 marker showed a significant difference between the C and NR groups. The analysis of cytokines showed a significant difference in TNF-α between the C and CP groups, C and NB groups, CP and NR groups, and NB and NR groups. IL-6 and InF-δ showed no significant difference between all groups. IL-10 showed significant differences between the C and NR groups, C and R groups, and CP and NR groups. Conclusion: NR prevented the evolution of neuroinflammation.

  • Open Access

    Estrogenic Disruption by Pesticides Exposure Associated with Breast Cancer: A Systematic Review Focusing on Epigenetic Mechanisms

    by Maria Elvira Ribeiro Cordeiro, Amanda Razera, Kamila Dallabrida, Barbara Mendes Paz Chao, Ana Carolina Dorigoni Bini, Patricia Pacheco Tyski Suckow, Eliane Gonçalves De Jesus Fonseca, Angela Dubiela Julik, Ivo Ilvan Kerppers, Emerson Carraro

    Breast cancer (BC) has been highlighted worldwide in view of its high prevalence. There are several risk factors that can be associated with the occurrence of BC, such as reproductive aspects, genetic mutations and family history. In this sense, lifestyle and environmental conditions may also be relevant - factors that are related to environmental contamination by pesticides, which in Brazil stands out, given the high consumption rates, therefore, exposure of the population. Since some types of BC associate themselves to the positive regulation of ERs, being sensitive to certain pesticides, it is valid to assume the existence, thus, an epigenetic association between cases. Thus, through a systematic review of the literature of studies reporting pesticides that alter estrogenic expression and activity and esstablish a risk for BC, focusing on epigenetic mechanisms. Descriptors were used and inclusion and exclusion criteria were established, so that 195 articles were found, and 3 were selected by the criteria. It is evident the existence of a relationship between estrogenic regulation and activity according to mechanisms that interfere in the expression of associated control genes, and the set of these factors is determinant for the increased risk of developing BC. However, the epigenetic genetic mechanisms described, associated with BC, are not standardized, and further research in the area is necessary in order to delineate more clearly the epigenetic aspects that permeate the disease.


  • The Effect of Cecropia glaziovii Gel on the Healing Process: Influence on the Balance between Cytokines and Growth Factors

    by Patricia Pacheco Tyski Suckow, Ana Carolina Dorigoni Bini, Maria Elvira Ribeiro Cordeiro, Andressa Panegalli Hosni, Angela Dubiela Julik, Eliane Gonçalves de Jesus Fonseca, Ivo Ilvan Kerppers, Flávio Henrique Reginatto, Carolina Panis, Paulo Renato De Oliveira

    The physiological regulation of wound healing depends on an interaction between different cells and mediators. Cecropia glaziovii is considered a model for the development of phytomedicines for health use due to its pharmacological activities attributed to the presence of flavonoids, procyanidins, catechins, and glycosides. Therefore, the aim of the study was to analyze the anti-inflammatory effects of Cecropia glaziovii gel on the healing of skin lesions in an experimental model. For this purpose, a 3% CMC gel incorporated with the 5% aqueous extract of Cecropia glaziovii was developed. The experimental stage was performed using a dorsal punch model. The sample was composed of 48 Wistar rats, divided into two groups: PC, treated only with base gel, and CEC Cecropia, treated with Cecropia glaziovii gel. The groups were subdivided into 3, 7, 14, and 21 days of treatment. We performed VEGF-α and TGF-β1 analyses by immunohistochemistry, IL-10 and IL-12 analyses by flow cytometry, total collagen analysis by polarized light microscopy, macroscopic, and statistical analysis. The treatment provided anti-inflammatory activity acting on the balance of cytokines production and growth factors, stimulating the collagen deposition necessary for the effectiveness of the healing process.


  • Immunohistochemistry Analysis of Animals with Post-Ischemic Stroke Treated with LED

    by Eliane Gonçalves de Jesus Fonseca, Felipe Figueiredo Moreira, Ana Carolina Dorigoni Bini, Maria Elvira Ribeiro Cordeiro, Andressa Panegalli Hosni, Amanda Razera, Patricia Pacheco Tyski Suckow, Angela Dubiela Julik, Josiane Lopes, Ivo Ilvan Kerppers, et al.

    Objective: To evaluate the effects of 630nm LED and 904nm LED in animals subjected to ischemic stroke, using the immunohistochemistry of these animals as analysis parameters. Methodology: The present work presents an experimental study with a controlled intervention that included 75 male Wistar rats. The animals were allocated into three groups: a control group consisting of 15 animals without treatment, a group treated with 630nm LED, and a group treated with0 904nm LED, composed of 30 animals each. All animals underwent stereotaxic surgery for electrode implantation and subsequent electrolyte injury. The results were compared on days 3, 7, and 21 of treatment after surgery. Results: The immunohistochemical analysis showed an improvement in the inflammatory response and tissue repair of the animals of both groups treated. Conclusion: The present study suggests that the treatments with 630nm LED and 904nm LED favored a significant response, which may be a promising technique because of its simplicity, low cost, and easy application.

  • Effects of α-Humulene and its Nanoparticles in Experimental Model of Alzheimer's Disease: Behavioral Analysis and Anti-Inflammatory Activity

    by Maria Elvira Ribeiro Cordeiro, Luana Rodrigues Vasconcelos, Heron Bittencourt, Flávio Klinpovous Kerppers, Andressa Panegalli Hosni, Ivo Ilvan Kerppers, Rubiana Mara Mainardes, Christiane Schineider Machado Kolc, Ana Carolina Dorigoni Bini, Patricia Pacheco Tyski Suckow, et al.

    The aim was to analyze the effects of α-humulene in experimental models of Alzheimer’s disease (AD). A sample composed of 33 rats, divided into the NC group: 3 animals, for analysis of normal tissue and behavior, PC: 10 animals submitted to induction of AD by application of β-amyloid, without treatment, HUM: 10 animals submitted to induction of AD and treated with α-humulene, and NHUM: 10 animals submitted to induction of AD and treated with α-humulene nanoparticles. Treatment was performed once daily for 14 days at a dose of 6.5µg, orally. The animals were submitted to behavioral tests of spatial memory and aversive memory, the cytokines TNF, IL-10, IL-2 and IL-4 were analyzed by flow cytometry. The treated animals obtained superior cognitive performance and expressed lower levels of inflammatory markers, with better results in the group with better results in the NHUM.


  • Open Access

    Efeito do equilíbrio neuromuscular na análise do equilíbrio estático em idosos / Effect of neuromuscular balance on static balance analysis in the elderly

    by Felipe Figueiredo Moreira, Ana Paula Santos Tartari, Mário César da Silva Pereira, Ivo Ilvan Kerppers, Maria Elvira Ribeiro Cordeiro, Flávio Klinpovous Kerppers, Eliane Goncalves de Jesus Fonseca, Patricia Pacheco Tyski Suckow, Pamela Taina Licoviski, Ana Carolina Dorigoni Bini

    Efeito do equilíbrio neuromuscular na análise do equilíbrio estático em idosos / Effect of neuromuscular balance on static balance analysis in the elderly

  • Pain neuromodulation exerted by Ruta graveolens aqueous extract in experimental models of nociception/ Neuromodulação da dor exercida pela Ruta graveolens extrato aquoso em modelos experimentais de nocicepção

    by Flávio Klinpovous Kerppers, Maria Elvira Ribeiro Cordeiro, Tatiane Budniak Mazur, Heron Bittencourt, Karoline Penteado da Luz, Andressa Panegalli Hosni, Ivo Ilvan Kerppers, Ana Carolina Dorigoni Bini, Felipe Figueiredo Moreira, Patricia Pacheco Tyski Suckow, et al.

    Introduction: The use of medicinal plants for therapeutic purposes has been common practice since antiquity. Ruta graveolens L., commonly known as rue, has been shown to have antiparasitic, antioxidant, antibacterial and allelopathic activity. Objective: The objective was to investigate the antinociceptive effect of rue, as well as the mechanisms behind this effect. Materials and Methods: The sample consisted of 40 male Norvegicus (Wistar) rats, randomly divided into a positive control and three treatment groups administered Ruta graveolens L. aqueous extract at the following doses: 50 mg/kg, 100 mg/kg or 500 mg/kg, p.o. The experimental models of nociception used in this study to assess effectiveness of the treatments were the formalin and capsaicin tests. Five days prior to nociceptive challenges, the tail immersion assay was conducted to determine baseline pain threshold. Results: Antinociceptive activity was observed at Ruta graveolens L. aqueous extract concentrations of 50 mg/kg and 100mg/kg. 500 mg/kg induced pro-nociceptive activity with activation of the L-arginine-oxide-nitric system. Conclusion: These results suggest Ruta graveolens L. aqueous extract antinociceptive activity, and possible antagonism towards receptors

  • Quercetin action on pain modulation/ Ação da quercetina sobre a modulação da dor

    by Maria Elvira Ribeiro Cordeiro, Flávio Klinpovous Kerppers, Luiza Ferreira Cunha, Ketllin Bragnholo, Luana Rodrigues Vasconcelos, Andressa Panegalli Hosni, Ivo Ilvan Kerppers, Ana Carolina Dorigoni Bini, Felipe Figueiredo Moreira, Pamela Taina Licoviski, et al.

    Background: Quercetin is a flavonoid widely found in plant kingdom and target of studies in pharmacological area due to its potent antinociceptive effect compared to analgesics used in conventional therapies. The aim was to evaluate its antinociceptive activity and antinociception mechanism. Methods: For this, 40 Norvegicus Wistar rats were used, divided into 4 groups: Q50 (treated with quercetin 50 mg/Kg), Q100 (treated with quercetin 100 mg/Kg), Q500 (treated with quercetin 500 mg/Kg) and Positive control (PC) without quercetin treatment), who were submitted through the pain induction methods by tail immersion and formalin in the first step to assess antinociceptive action and in the second step, tail immersion method receiving antagonists from opioid, cholinergic and nitric oxide - L-arginine to evaluate the action mechanism. Results: Quercetin antinociceptive activity was verified at the dose of 50 mg/kg and 100 mg/kg in tail immersion test after formalin injection, with better performance at the dose of 50 mg/kg. There were no statistically significant results in paw opening and capsaicin tests. Quercetin demonstrated a possible influence on opioid and cholinergic pathway, which was not observed on the nitric acid - L-arginine pathway in view of parameters tested. Conclusion: Quercetin performed the best antinociceptive activity at a dose 50 mg/kg and there was a possible influence on opioid and cholinergic pathways.